This episode covers Neurophet’s third FDA clearance for multimodal Alzheimer’s neuroimaging with automated lesion detection, Medtronic’s Stealth AXiS spine platform introducing real time segmental motion tracking, and GE HealthCare’s AI driven cardiac ultrasound system reporting eighty percent keystroke reduction. Additional coverage includes real world evidence from stroke triage studies across NHS and U.S. emergency settings, FDA’s rescission of the Laboratory Developed Test rule, updated real world evidence guidance emphasizing relevance and reliability assessment, and revised cybersecurity and AI lifecycle management frameworks for medical device software.
